To include your compound in the COVID-19 Resource Center, submit it here.

DanDrit Biotech USA, Oxford BioMedica, myTomorrows cancer news

Online patient platform myTomorrows will offer patients access to DanDrit's MelCancerVac and to an undisclosed therapeutic cancer vaccine

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE